Abstract
Herein, we demonstrate the synthesis and functionalization of α-boryl aldoximes from α-boryl aldehydes, with no sign of c-to-n boryl migration. selective modification of the oxime functionality enables access to a wide range of borylated compounds, such as borylated heterocycles and N-acetoxyamides. by reducing the α-boryl aldoximes, mida deprotection yields the corresponding β-boryl hydroxylamines. as part of this study, we also demonstrate the utility of the boryl aldoxime motif in peptide conjugation.
Oximes represent a class of highly diverse compounds that have found utility in numerous synthetic applications. The oxime functionality can be introduced into a molecule through the condensation between carbonyls and hydroxylamines, nitrosation of hydrocarbons, and reduction of nitro compounds.1 The resulting oximes can be subsequently applied towards the synthesis of more complex structures. Oximes have been utilized in the synthesis of nitrile oxides2,3 to afford a variety of cycloadducts such as isoxazolines,4 isoxazoles5 and oxadiazoles.6 Metal-catalyzed rearrangements of oxime-containing molecules have also yielded biologically relevant structures, such as oxazepines,7 pyridols,8 pyridines,9 and pyrroles.10
Compared to imines and hydrazones, oximes exhibit much greater hydrolytic stability.11 The relative stability of oximes compared to their imine analogues can be attributed to the electron donating ability of the oxygen lone pair, which causes a decrease in the electrophilicity of the carbon center and makes the oxime adduct less prone to hydrolysis.12 In addition, oximes are less prone to protonation at the imine nitrogen position due to the inductive effects of the hydroxyl group.11 As a result of their intrinsic hydrolytic stability, oximes are also desired functional moieties in bioconjugation chemistry.13
Among the numerous strategies,14 oxime ligation is an attractive approach because it is chemoselective and compatible with most biomolecule functionalities.12 Another method to conjugate biomolecules is through the use of aryl boronic acids, which can either act as the conjugate unit,15 enhance the properties of a particular ligate,16 form stable adducts with the linkage,17 or catalyze its formation.18 Recently, it has been demonstrated that proximal boronic acids are able to increase the rate of oxime condensation at neutral pH.19
Beyond applications in bionconjugation, molecules containing both oxime and boronic acid functional moieties have been applied towards the synthesis of boron-containing heterocycles, such as borylated pyridines20 and benzoxaborines.21 Additionally, studies on the asymmetric reduction of β-boronate oxime ethers to their corresponding amine have been conducted.22 Despite the prevalence of borylated oximes in the literature, compounds containing an oxime alpha to an aliphatic boronate have not been previously reported (Figure 1). This connectivity and the use of an aliphatic boronate is expected to influence the properties of the corresponding borylated oximes providing access to novel borylated compounds. Inspired by the utility of oximes in both chemical biology and synthetic chemistry, we became interested in utilizing the amphoteric α-N-methyliminodiacetyl (MIDA) boryl aldehyde23 to access α-MIDA boryl aldoximes and study their corresponding reactivity profile and application.
Figure 1.

The α-boryl aldoxime motif.
Previous attempts to condense α-boryl aldehydes and primary amines has been met with some difficulty. For instance, the major product of condensation with aniline is the N-boryl enamine, which is the result of a 1,3-migration of the boryl group from carbon-to-nitrogen.24,25 This is in contrast to condensation with tert-butylsufinamide, where the C-boryl imine is the major product with N-boryl enamine as the byproduct. Boron migration from carbon-to-nitrogen leads to a decrease in hydrolytic stability and product decomposition. We have since reported a number of methods to circumvent the boryl migration through in situ trapping of the condensation intermediates. These include trapping the enamine intermediate via the addition of an acyl halide to produce C-boryl enamides,26 or alternatively, trapping the imine species via reductive amination.25 Herein, we present a new strategy to overcome 1,3-boryl migration. The condensation between α-boryl aldehyde and hydroxylamine exclusively furnishes α-boryl aldoximes with no signs of boryl migration. By preserving the C–B bond, we were able to modify the oxime group in the vicinity of boron.
The condensation between α-boryl aldehyde (1) with hydroxylamine (2) in the presence of catalytic aniline27 and under pH buffered conditions in acetonitrile successfully afforded α-MIDA boryl aldoximes 3a – 3e. Full conversion of the aldehyde into the desired α-boryl aldoxime was achieved with excess hydroxylamine hydrochloride in less than 30 minutes. In most cases, the product readily decomposed when reacted for longer than 30 minutes. Fortunately, performing a work-up immediately after reaction completion led to the isolation of various α-boryl aldoximes in high yields (Table 1). The substituted boryl aldehydes yielded the E-aldoxime, while unsubstituted aldoxime 3c, existed as a 1.5:1 E:Z mixture as determined by 1H NMR spectroscopy. Aldoxime 3b was crystallized from deuterated acetonitrile to obtain X-ray quality crystals. In the crystal, two molecules of the E-aldoxime participate in intermolecular hydrogen bonding in a dimeric fashion (Figure 2). In addition to the unsubstituted aldoximes, O-benzyl aldoximes were accessed under a different set of conditions (Table 1). Aldoximes 4a – 4c were obtained in good yields via the condensation of α-boryl aldehyde and O-benzylhydroxylamine hydrochloride with triethylamine in acetonitrile at 50 °C.
Table 1.
Preparation of α-MIDA boryl aldoximes.
| ||||
|---|---|---|---|---|
|
| ||||
| Entry | R1 | R2 | Product | Yield (%)a |
| 1 | phenyl | H | 3a | 80b |
| 2 | cyclohexyl | H | 3b | 75b |
| 3 | H | H | 3c | 75b (1.5:1 E:Z) |
| 4 | benzyl | H | 3d | 94b |
| 5 | isobutyl | H | 3e | 95b |
| 6 | phenyl | benzyl | 4a | 80c (11:1 E:Z) |
| 7 | benzyl | benzyl | 4b | 88c |
| 8 | isobutyl | benzyl | 4c | 93c |
Isolated yields after flash column chromatography.
Reaction conditions: 1 (1 equiv.) and 2 (3 equiv.) dissolved in 1:1 MeCN: 0.1 M pH 4.5 sodium acetate buffer (0.1 M). Aniline (1 equiv.) added and stirred for 10-30 mins.
1 (1 equiv.) and 2 (1.5 equiv.) dissolved in MeCN (0.2 M). Et3N (1.5 equiv.) added and stirred at 50 °C for 48 h.
Figure 2.

Molecular structure of α-MIDA boryl aldoxime 3b.
We investigated the synthesis of MIDA boryl oxadiazoles and isoxazoles through the use of our α-boryl aldoxime. The aldoximes were treated with N-chlorosuccinimide (NCS) in DMF to afford the aldoximoyl chlorides (5), which were unstable to purification. The crude product was immediately subjected to triethylamine and superstoichiometric equivalents of nitriles to furnish the corresponding benzylic MIDA boryl oxadiazoles in moderate to excellent yields. A number of substrates were synthesized from acetonitrile (7a), trichloroacetonitrile (7b – 7c), benzonitrile (7d – 7f) and 2-fluorobenzonitrile (7g, Scheme 1). In addition to cycloaddition with nitriles, electrophilic alkynylesters, such as dimethyl acetylenedicarboxylate (DMAD) and ethyl-2-butynoate were also competent dipolarophiles to furnish substituted isoxazoles 7h – 7j.
Scheme 1.

Selective oxidation and cycloaddition of α-MIDA boryl aldoximes.
Aldoximes have been used towards the synthesis of N-acetoxyamides, which are present in a variety of biologically active molecules with anti-inflammatory, anti-asthmatic, and anti-cancer properties.28 In the presence of diacetoxyiodobenzene and acetic acid, aldoximes are converted to the nitrile oxide (6) in situ and trapped by acetic acid (8) to give the desired N-acetoxyamide after an intramolecular acyl transfer from C-to-O. We found the transformation to be compatible with the MIDA protecting group and produced the boron containing N-acetoxyamide products 9a – 9d in good yields (Scheme 2).
Scheme 2.

Synthesis and scope of borylated N-acetoxyamides.
MIDA boronates have been successfully deprotected to the free boronic acid using mild aqueous acid and base in various solvents.25,29 With a number of α-boryl aldoximes and their downstream derivatives in hand, we sought to investigate their compatibility under MIDA deprotection conditions. A series of variations were attempted, such as stirring the compounds in aqueous NaOH or HCl, however, exclusive formation of the protodeboronated products was observed. Empirically, we came to the conclusion that sp3 MIDA boronates with a β-sp2 center to boron were unstable as their free boronic acids (Figure 2a). Recently, our group demonstrated that the reductive conjugation of α-boryl aldehydes with a variety of amines followed by MIDA deprotection is an efficient route to hydrolytically stable β-aminoboronic acid derivatives.25,30 In contrast, these products contain a β-sp3 center relative to boron, which are more stable compared to the β-imino boronic acids (Figure 2b). Using this knowledge to our advantage, we attempted the synthesis of β-boryl hydroxylamine derivatives by employing our α-boryl aldoximes. A number of conditions were screened for the reduction of O-benzylaldoxime 4a, wherein sodium cyanoborohydride in a 2:1 acetonitrile:water mixture with 6 equivalents of HCl led to full conversion in 15 minutes (Scheme 3). The hydroxylamines were unstable to normal phase silica gel chromatography, but were isolable using reverse phase flash chromatography in good yields (10a – 10b). These reduction conditions were not compatible with the unprotected aldoxime 3a and the major product observed by LC/MS analysis was the protodeboronated hydroxylamine.
Figure 2.

Hypothesized trends of boronic acid stability.
Scheme 3.

Preparation of boron-containing hydroxylamines.
The synthesized β-MIDA boryl hydroxylamines were then subjected to MIDA deprotection conditions. Compounds 10a and 10b were stirred in 10 equivalents of sodium bicarbonate in a 20:1 MeOH:H2O mixture. The desired boronic acids were detected by LCMS and confirmed by 11B NMR spectroscopy, wherein a diagnostic change in chemical shift from 12 ppm to 30 ppm was observed. The products were purified by reverse phase flash chromatography and isolated in good yields (11a and 11b, Scheme 3). In agreement with our hypothesis, reduction of the oxime to the corresponding hydroxylamine enabled successful MIDA deprotection, since sp3 MIDA boronates are stable as their corresponding free boronic acid when they are beta to a sp3 carbon center.
Based on their high stability and straightforward preparation, oxime ligation has become a commonly employed strategy for conjugating biologically relevant molecules. Guided by boron’s versatility in chemical biology,15–19 we sought to demonstrate the facile conjugation of our MIDA boronates onto a biomolecule. Aminooxyacetyl-functionalized peptide 12 was dissolved in pH 4.5 sodium acetate buffer and combined with two equivalents of MIDA-boryl aldehyde 1c (Figure 3a). Clean conversion into the desired borylated peptide 13 was achieved in one hour at room temperature. Liquid chromatography-mass spectrometry (LC-MS) was utilized to confirm the presence of product (Figure 3b). Recently, it has been reported that alkyl boronic acids associate strongly with carbohydrate derivatives.30 This conjugation approach has the potential to equip biologically relevant architectures with saccharide-binding abilities.16,30 Additionally, this methodology represents an attractive route to produce isotopically labelled peptides.31
Figure 3.

a. Oxime ligation of aminooxyacetyl-functionalized peptide 12 with MIDA-boryl aldehyde 1c. A 250 μM solution of 1c in MeCN was combined with a 500 μM solution of 12 in 50 mM pH 4.5 sodium acetate buffer. The final volume was brought to 1 mL using the buffered solution and the reaction was carried out for one hour at 25 °C. Following filtration, the sample was run on LC-MS to confirm and detect product. b. LC-MS trace of the starting material (top) and crude conjugation reaction (bottom).
In summary, we have demonstrated the mild synthesis of a novel class of amphoteric building blocks – α-boryl aldoximes. We successfully applied these molecules towards the synthesis of previously inaccessible MIDA boryl oxadiazoles, isoxazoles, and borylated N-acetoxyamides. The reduction and subsequent MIDA deprotection of α-boryl aldoximes led to the isolation of β-boryl hydroxylamines. We demonstrated the value of our approach by applying it towards the conjugation to an aminooxyacetyl-functionalized peptide. Through a simple and efficient oxime linkage we can incorporate an alkyl boronate onto a biological target of interest and modify its properties.
Acknowledgments
This work was supported by NSERC (Discovery Grant and Canada Research Chairs Programs). We would like to thank Dr. Alan Lough for X-ray structure determination of 3a.
References
- 1.Mikhaleva AI, Zaitsev AB, Trofimov BA. Russ Chem Rev. 2006;75:797. [Google Scholar]
- 2.Liu K-C, Shelton BR, Howe RK. J Org Chem. 1980;45:3916. [Google Scholar]
- 3.Feuer H, editor. Nitrile oxides, Nitrones, and Nitronates in Organic Synthesis. John Wiley & Sons, Inc; New Jersey: 2008. [Google Scholar]
- 4.Hashimoto T, Maruoka K. Chem Rev. 2015;115:5366. doi: 10.1021/cr5007182. [DOI] [PubMed] [Google Scholar]
- 5.Kesornpun C, Aree T, Mahidol C, Ruchirawat S, Kittakoop P. Angew Chem Int Ed. 2016;55:3997. doi: 10.1002/anie.201511730. [DOI] [PubMed] [Google Scholar]
- 6.Yoshimura A, Nguyen KC, Klasen SC, Saito A, Nemykin VN, Zhdankin VV. Chem Comm. 2015;51:7835. doi: 10.1039/c5cc02009c. [DOI] [PubMed] [Google Scholar]
- 7.Nakamura I, Kudo Y, Terada M. Angew Chem Int Ed. 2013;52:7536. doi: 10.1002/anie.201302751. [DOI] [PubMed] [Google Scholar]
- 8.Wang S, Guo Y-Q, Ren Z-H, Wang Y-Y, Guan Z-H. Org Lett. 2017 doi: 10.1021/acs.orglett.7b00389. [DOI] [PubMed] [Google Scholar]
- 9.Zhao M-N, Ren Z-H, Yu L, Wang Y-Y, Guan Z-H. Org Lett. 2016;18:1194. doi: 10.1021/acs.orglett.6b00326. [DOI] [PubMed] [Google Scholar]
- 10.Ngwerume S, Camp JE. Chem Comm. 2011;47:1857. doi: 10.1039/c0cc04372a. [DOI] [PubMed] [Google Scholar]; Ran L, Ren Z-H, Wang Y-Y, Guan Z-H. Green Chem. 2014;16:112. [Google Scholar]
- 11.Kalia J, Raines RT. Angew Chem Int Ed. 2008;47:7523. doi: 10.1002/anie.200802651. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Ulrich S, Boturyn D, Marra A, Renaudet O, Dumy P. Chem Eur J. 2014;20:34. doi: 10.1002/chem.201302426. [DOI] [PubMed] [Google Scholar]
- 13.Kolmel DK, Kool ET. Chem Rev. 2017;117:10358. doi: 10.1021/acs.chemrev.7b00090. [DOI] [PMC free article] [PubMed] [Google Scholar]; Agten SM, Dawson PE, Hackeng TM. J Pept Sci. 2016;22:271. doi: 10.1002/psc.2874. [DOI] [PubMed] [Google Scholar]; Crisalli P, Hernandez AR, Kool ET. Bioconj Chem. 2012;23:1969. doi: 10.1021/bc300344b. [DOI] [PMC free article] [PubMed] [Google Scholar]; Rashidian M, Mahmoodi MM, Shah R, Dozier JK, Wagner CR, Distefano MD. Bioconj Chem. 2013;24:333. doi: 10.1021/bc3004167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Algar WR, Dawson PE, Medintz IL, editors. Chemoselective and Bioorthogonal Ligation Reactions: Concepts and Applications. Wiley-VCH; Germany: 2017. [Google Scholar]; Koniev O, Wagner A. Chem Soc Rev. 2015;44:5495. doi: 10.1039/c5cs00048c. [DOI] [PubMed] [Google Scholar]; Kaila J, Raines RT. Curr Org Chem. 2010;14:138. doi: 10.2174/138527210790069839. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Meadows MK, Roesner EK, Lynch VM, James TD, Anslyn EV. Org Lett. 2017;19:3179. doi: 10.1021/acs.orglett.7b01198. [DOI] [PubMed] [Google Scholar]; Scarano W, Lu H, Stenzel MH. Chem Commun. 2014;50:6390. doi: 10.1039/c3cc49100e. [DOI] [PubMed] [Google Scholar]; Huang L-L, Jin Y-J, Zhao D, Yu C, Hao J, Xie H-Y. Anal Bioanal Chem. 2014;406:2687. doi: 10.1007/s00216-014-7651-9. [DOI] [PubMed] [Google Scholar]
- 16.Gunnoo SB, Madder A. Org Biomol Chem. 2016;14:8002. doi: 10.1039/c6ob00808a. [DOI] [PubMed] [Google Scholar]; Anderson KA, Smith TP, Lomax JE, Raines RT. ACS Chem Biol. 2016;11:319. doi: 10.1021/acschembio.5b00966. [DOI] [PMC free article] [PubMed] [Google Scholar]; Whyte GF, Vilar R, Woscholski R. J Chem Biol. 2013;6:161. doi: 10.1007/s12154-013-0099-0. [DOI] [PMC free article] [PubMed] [Google Scholar]; Ellis GA, Palte MJ, Raines RT. J Am Chem Soc. 2012;134:3631. doi: 10.1021/ja210719s. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Bandyopadhyay A, Cambray S, Gao J. J Am Chem Soc. 2017;139:871. doi: 10.1021/jacs.6b11115. [DOI] [PMC free article] [PubMed] [Google Scholar]; Dilek O, Lei Z, Mukherjee K, Bane S. Chem Commun. 2015;51:16992. doi: 10.1039/c5cc07453c. [DOI] [PMC free article] [PubMed] [Google Scholar]; Cal PMSD, Frade RFM, Cordeiro C, Gois PMP. Chem Eur J. 2015;21:1. [Google Scholar]; Cal PMSD, Vicente JB, Pires E, Coelho AV, Veiros LF, Cordeiro C, Gois PMP. J Am Chem Soc. 2012;134:10299. doi: 10.1021/ja303436y. [DOI] [PubMed] [Google Scholar]
- 18.Bandyopadhyay A, Gao J. Chem Eur J. 2015;21:14748. doi: 10.1002/chem.201502077. [DOI] [PMC free article] [PubMed] [Google Scholar]; Draganov AB, Wang K, Holmes J, Damera K, Wang D, Dai C, Wang B. Chem Commun. 2015;51:15180. doi: 10.1039/c5cc05890b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Schmidt PJ, Stress CJ, Gillingham DG. Chem Sci. 2015;6:3329. doi: 10.1039/c5sc00921a. [DOI] [PMC free article] [PubMed] [Google Scholar]; Stress CJ, Schmidt PJ, Gillingham DG. Org Biomol Chem. 2016;14:5529. doi: 10.1039/c6ob00168h. [DOI] [PubMed] [Google Scholar]; Gillingham DG. Org Biomol Chem. 2016;14:7606. doi: 10.1039/c6ob01193d. [DOI] [PubMed] [Google Scholar]
- 20.Mora-Rado H, Bialy L, Czechitzky W, Mendez M, Harrity JPA. Angew Chem. 2016;128:5928. doi: 10.1002/anie.201601084. [DOI] [PubMed] [Google Scholar]
- 21.Groziak MP, Chen L, Yi L, Robinson PD. J Am Chem Soc. 1997;119:7817. [Google Scholar]; Dewar MJS, Dougherty RC. J Am Chem Soc. 1962;84:2648. [Google Scholar]; Snyder HR, Reedy AJ, Lennarz WJ. J Am Chem Soc. 1958;80:835. [Google Scholar]
- 22.Sailes HE, Watts JP, Whiting A. Tetrahedron Lett. 2000;41:2457. [Google Scholar]; Mears RJ, Sailes HE, Watts JP, Whiting A. J Chem Soc Perkin Trans. 2000;1:3250. [Google Scholar]
- 23.He Z, Yudin AK. J Am Chem Soc. 2011;133:13770. doi: 10.1021/ja205910d. [DOI] [PubMed] [Google Scholar]; Li J, Burke MD. J Am Chem Soc. 2011;133:13774. doi: 10.1021/ja205912y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.He Z, Zajdlik A, Yudin AK. Acc Chem Res. 2014;47:1029. doi: 10.1021/ar400210c. [DOI] [PubMed] [Google Scholar]
- 25.Diaz DB, Scully CCG, Liew SK, Adachi S, Trinchera P, St Denis JD, Yudin AK. Angew Chem Int Ed. 2016;55:12659. doi: 10.1002/anie.201605754. [DOI] [PubMed] [Google Scholar]
- 26.St Denis JD, Zajdlik A, Tan J, Trinchera P, Lee CF, He Z, Adachi S, Yudin AK. J Am Chem Soc. 2014;136:17669. doi: 10.1021/ja510963k. [DOI] [PubMed] [Google Scholar]
- 27.Dirksen AD, Hackeng TM, Dawson PE. Angew Chem Int Ed. 2006;45:7581. doi: 10.1002/anie.200602877. [DOI] [PubMed] [Google Scholar]
- 28.Ghosh H, Patel BK. Org Biomol Chem. 2010;8:384. doi: 10.1039/b917096k. [DOI] [PubMed] [Google Scholar]
- 29.Gonzalez JA, Ogba OM, Morehouse GF, Rosson N, Houk KN, Leach AG, Cheong PH-Y, Burke MD, Lloyd-Jones GC. Nat Chem. 2016;8:1067. doi: 10.1038/nchem.2571. [DOI] [PMC free article] [PubMed] [Google Scholar]; Zajdlik A, Wang Z, Hickey JL, Aman A, Schimmer AD, Yudin AK. Angew Chem. 2013;125:8569. doi: 10.1002/anie.201302818. [DOI] [PubMed] [Google Scholar]
- 30.Garrett GE, Diaz DB, Yudin AK, Taylor MS. Chem Commun. 2017;53:1809. doi: 10.1039/c6cc09640a. [DOI] [PubMed] [Google Scholar]
- 31.Liu Z, Lin K-S, Benard F, Pourghiasian M, Kiesewetter DO, Perrin DM, Chen X. Nat Protoc. 2015;10:1423. doi: 10.1038/nprot.2015.090. [DOI] [PMC free article] [PubMed] [Google Scholar]; Liu Z, Pourghiasian M, Radtke MA, Lau J, Pan J, Dias GM, Yapp D, Lin K-S, Benard F, Perrin DM. Angew Chem. 2014;126:12070. doi: 10.1002/anie.201406258. [DOI] [PubMed] [Google Scholar]; Carberry P, Lieberman BP, Ploessl K, Choi SR, Haase DN, Kung HF. Bioconjugate Chem. 2011;22:642. doi: 10.1021/bc1004262. [DOI] [PMC free article] [PubMed] [Google Scholar]; Ting R, Adam MJ, Ruth TJ, Perrin DM. J Am Chem Soc. 2005;127:13094. doi: 10.1021/ja053293a. [DOI] [PubMed] [Google Scholar]
